April 15th, 2017
•Here, we show the generation of human engineered heart tissue from induced pluripotent stem cells (hiPSC)-derived cardiomyocytes. We present a method to analyze contraction force and exemplary alteration of contraction pattern by the hERG channel inhibitor E-4031. This method shows high level of robustness and suitability for cardiac drug screening.
Vídeos Relacionados
Bioluminescence Imaging for Assessment of Immune Responses Following Implantation of Engineered Heart Tissue (EHT)
Self-reporting Scaffolds for 3-Dimensional Cell Culture
Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles
Hollow Fiber Bioreactors for In Vivo-like Mammalian Tissue Culture
Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies
Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados